Preferred Drug List Changes
The following changes have been made to the Nebraska PDL. Changes are effective January 22, 2022.
| Nebraska PDL Therapeutic Drug Class | Change effective January 22, 2022 |
|---|---|
| BRONCHODILATORS, BETA AGONIST | ALBUTEROL HFA (PROAIR) (INHALATION) → PREFERRED |
| MOVEMENT DISORDERS | INGREZZA (ORAL) → PREFERRED |
| OPHTHALMICS FOR ALLERGIC CONJUNCTIVITIS | OLOPATADINE (PATANOL) (OPHTHALMIC) → PREFERRED OLOPATADINE OTC (PATADAY ONCE DAILY) (OPHTHALMIC) → PREFERRED OLOPATADINE OTC (PATADAY TWICE A DAY) (OPHTHALMIC) → PREFERRED PAZEO (OPHTHALMIC) → NON PREFERRED |
| OPHTHALMICS, GLAUCOMA AGENTS | ALPHAGAN P 0.15% (OPHTHALMIC)→ PREFERRED |
| HEMOPHILIA TREATMENT | ALPROLIX (INTRAVEN) → PREFERRED |
| ONCOLOGY, ORAL - PROSTATE | ZYTIGA (ORAL) → PREFERRED |